930 related articles for article (PubMed ID: 11224597)
21. Unclassified renal cell carcinoma: a report of 56 cases.
Lopez-Beltran A; Kirkali Z; Montironi R; Blanca A; Algaba F; Scarpelli M; Yorukoglu K; Hartmann A; Cheng L
BJU Int; 2012 Sep; 110(6):786-93. PubMed ID: 22404824
[TBL] [Abstract][Full Text] [Related]
22. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
23. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of sarcomatoid renal cell carcinoma].
Ohba K; Koga S; Nishikido M; Miyata Y; Noguchi M; Kanetake H; Kanda S; Hayashi T; Yamada J
Hinyokika Kiyo; 2003 Mar; 49(3):131-3. PubMed ID: 12728524
[TBL] [Abstract][Full Text] [Related]
25. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
26. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
27. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
28. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
29. [Four cases of sarcomatoid renal cell carcinoma].
Takada T; Kinouchi T; Kinoshita T; Hatano K; Kobayashi M; Inoue H; Hara T; Yamaguchi S
Hinyokika Kiyo; 2009 Feb; 55(2):93-7. PubMed ID: 19301614
[TBL] [Abstract][Full Text] [Related]
30. [Sarcomatoid renal cell carcinoma: follow-up of a series of 23 patients].
Pamela A; Arnoux V; Long JA; Rambeaud JJ; Lechevallier E
Prog Urol; 2014 Apr; 24(5):301-6. PubMed ID: 24674336
[TBL] [Abstract][Full Text] [Related]
31. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
[TBL] [Abstract][Full Text] [Related]
32. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
33. Renal cell carcinoma in South Korea: a multicenter study.
Kim H; Cho NH; Kim DS; Kwon YM; Kim EK; Rha SH; Park YW; Shim JW; Lee SS; Lee SN; Lee J; Lee JS; Lee TJ; Jung SJ; Jung SH; Chung JH; Cho HY; Joo HJ; Choi YJ; Choi C; Han WS; Hur B; Ro JY;
Hum Pathol; 2004 Dec; 35(12):1556-63. PubMed ID: 15619217
[TBL] [Abstract][Full Text] [Related]
34. Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma.
Shuch B; Bratslavsky G; Shih J; Vourganti S; Finley D; Castor B; Treat E; Linehan WM; Pantuck AJ; Said JW; Belldegrun AS
BJU Int; 2012 Jun; 109(11):1600-6. PubMed ID: 22221668
[TBL] [Abstract][Full Text] [Related]
35. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
36. [Sarcomatoid renal carcinoma].
Leucumberri Castaños D; Podilla Nieva J; Albisu Tristán A; Pertusa Peña CP
Arch Esp Urol; 1998 Oct; 51(8):772-5. PubMed ID: 9859582
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
[TBL] [Abstract][Full Text] [Related]
38. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
[TBL] [Abstract][Full Text] [Related]
39. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
Diolombi ML; Cheng L; Argani P; Epstein JI
Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
[TBL] [Abstract][Full Text] [Related]
40. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
